Online Only Articles

Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells

Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus;Department of Medical and Molecular Genetics, King’s College London, London, UK
Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany;Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Freiburg, Germany
Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus;Cyprus School of Molecular Medicine, Nicosia, Cyprus
Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany;Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Freiburg, Germany
Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus;Cyprus School of Molecular Medicine, Nicosia, Cyprus
Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus;Department of Medical and Molecular Genetics, King’s College London, London, UK
Thalassemia Center, Cyprus Ministry of Health, Cyprus
Thalassemia Center, Cyprus Ministry of Health, Cyprus
Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany;Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Freiburg, Germany
Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany;Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Freiburg, Germany
Department of Medical and Molecular Genetics, King’s College London, London, UK
Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus;Cyprus School of Molecular Medicine, Nicosia, Cyprus
Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany;Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Freiburg, Germany;Faculty of Medicine, University of Freiburg, Freiburg, Germany
Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus;Cyprus School of Molecular Medicine, Nicosia, Cyprus
Vol. 104 No. 11 (2019): November, 2019 https://doi.org/10.3324/haematol.2018.215178